Leearne Hinch
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Leearne Hinch
Chief Executive / INOVIQ
Dr Leearne Hinch is a biotechnology executive and consultant with extensive experience in the life science industry in general management, strategy, fundraising, business development and commercialisation. Dr Hinch has strategic, operational and technical experience in leading and managing the development and commercialisation of drug, device and animal health products.
She is also a director of commercialisation advisory Ingeneus Solutions, and previously held CEO and executive positions in ASX-listed biotechnology, multinational and private companies including Eustralis Pharmaceuticals, Immuron, OBJ, Holista CollTech, Chemeq and Virbac (Australia).
She is also a director of commercialisation advisory Ingeneus Solutions, and previously held CEO and executive positions in ASX-listed biotechnology, multinational and private companies including Eustralis Pharmaceuticals, Immuron, OBJ, Holista CollTech, Chemeq and Virbac (Australia).
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 291st | INOVIQ | 33% | 109% |
| 703rd | Frugl Group | 0% | -20% |
| 766th | Advanced Health Intelligence | -2% | -24% |
| 1615th | Nanollose | -60% | -21% |
| 1865th | Invex Therapeutics | -83% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
Year started and most recent title
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 157th |  | INOVIQ | $1.6m |
| 172nd | | Frugl Group | $806k |
| 173rd | | Advanced Health Intelligence | $772k |
| 175th |  | Invex Therapeutics | $459k |
| 176th |  | Nanollose | $412k |
201 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
